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Effects of Cocaine on Dopamine Receptor 
Gene Expression: A Study in the Postmortem 
Human Brain 
James H. Meador-Woodruff, Karley Y. Little, Scott P. Damask, 
Alfred Mansour, and Stanley J. Watson 
The effects of chronic cocaine exposure on dopamine DI and D2 receptor gene expression in 
the human brain were studied in postmortem samples from chronic cocaine abusing and 
matched control subjects. U~ing in situ hybridization and receptor autoradiography to examine 
messe ger ribonucleic acid (RNA ) and binding sites, respectively, neither D I nor Dz receptor 
expresshTn was found to be changed in the nucleus accumbens, caudate, putamen, or substantia 
nigra of the cocaine-exposed subjects. Although chronic cocaine exposure can produce al- 
terations in dopaminergic neurotransmission, sustained compensatory changes in dopamine 
receptor expression do not appear to occur in the human. 
Key Words: Receptors, dopamine, messenger RNA, in situ hybridization, cocaine, receptor 
binding, human brain 
Introduction 
Cocaine has myriad effects on a number of neurotrans- 
mitter systems in the brain. While influencing multiple 
systems, however, its effects on dopaminergic neurotrans- 
mission in the limbic system appear to be a critical mech- 
anism underlying the reinforcing properties of this drug 
(Kuhar et al 1991). Cocaine is able to block the dopamine 
transporter, which acts as a presynaptic reuptake site, thus 
effectively increasing intrasynaptic dopamine concentra- 
tion (Ritz et al 1987; Church et al 1987; lzenwasser et al 
1990). There is some evidence that there may be corn- 
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pensatory changes in dopamine receptor expression as well, 
which could be a primary effect or a secondary result of 
this increased intrasynaptic dopamine (Trulson and Ulissey 
1987; Gocders and Kuhar 1987; Kleven et a11990; Volkow 
et al 1990; Peris et al 1990; Mayfield et al 1992; Farfel et 
al 1992). 
The mesolimbic component of the dopamine system is 
one of the most likely sites of action of cocaine in the 
brain. This system originates in the dopamine-synthesizing 
cells of the ventral tegmental area, located in the medial 
mesencephalon, which send axons rostrally to terminate 
in limbic regions of the brain, including the nucleus ac- 
cumbens. Parallel to this system, the nigrostriatal system 
arises more laterally in the midbrain, sending fibers to the 
caudate and putamen. The nucleus accumbens as well as 
the caudate and putamen send fibers back to the midbrain 
cell groups, thus completing discrete neuroanatomical cir- 
cuits associated with reinforcement and motor functions. 
The specific subtypes of dopamine receptors located in 
these circuits appear to be complex. Although both D, and 
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D2 receptors have been identified in all anatomical regions 
associated with these systems, the recent cloning of mul- 
tiple dopamine receptor subtypes in the human has re- 
vealed an additional level of neurochemical organization. 
The dopamine receptors cluster into two larger families: 
the Dl-like family contains the D~ (Dearry et al 1990; 
Zhou et al 1990; Sunahara et al 1990) and D5 (Sunahara 
et al 1991; Weinshank et al 1991; Grandy et al 1991) 
receptors, and the D2-1ike family consists of the D2 (Grandy 
et al ! 989), D3 (Giros et al 1990), and D4 (Van Tol et al 
1991) receptors. In addition to D! and D2 receptor local- 
ization in both the motor and limbic dopamine circuits, 
the D 3 and D4 receptors also appear to be expressed in 
these systems, with particular enrichment in the limbic 
circuit (Bouthenet et ai 1991; Mengod et ai 1992; L6vesque 
et al 1992). The Dt and D2 receptors, however, are present 
in overwhelming abundance compared to the other do- 
pamine receptor subtypes. 
The present study was designed to characterize the ef- 
fects of chronic cocaine use on dopamine receptor binding 
as well as messenger RNA expression in the postmortem 
human brain. The focus was on the striatal and accumbens 
regions, which are heavily innervated by dopaminergic 
fibers originating m the midbrain, and contain high den- 
sities of dopamine receptors. We have initially chosen to 
focus on the D~ and D2 receptors, as they are the most 
abund mt and best understood of the five dopamine recep- 
tors in the circuits und.:r examination. 
Methods 
BRAIN ACQUISITION. Postmortem human brain spec- 
imens were obtained at autopsy from subjects suspected 
of chronic cocaine use, as well as from age-, gender-, and 
race-matched controls who were not suspected of recent 
substance abuse (Table 1). These autopsies were author- 
ized and performed by the Office of the Chief Medical 
Examiner, State of North Carolina, who found no evidence 
of neurological disease. Two blocks of brain tissue were 
obtained at autopsy: a midbrain slice ~ontaining the sub- 
stantia nigra and ventral tegmental area, and a rostral fore. 
brain block containing the caudate, putamen, and nucleus 
accumbens. These two blocks were frozen on powdered 
dry ice, and stored at -80°C. Nine pairs of midbrain 
blocks were obtained for this study, but only six pairs of 
the forebrain blocks were available. 
CLINICAL CHARACTERIZATION. A research psychia- 
trist and a psychologist identified and interviewed infor- 
mants for each subject. In all cases, an attempt was made 
to identify family members who could provide historical 
information. Informants included family members, neigh- 
bors, co-workers, police officers, physicians, medical ex- 
aminers, and media reporters. Interviews were conducted 
to obtain information to determine if subjects met DSM- 
III-R criteria (American Psychiatric Association 1987) for 
affective, anxiety, psychotic, and/or psychoactive sub- 
stance abuse disorders. After collection of these clinical 
data, DSM-III-R diagnoses were assigned at a consensus 
conference involving experienced research psychiatrists. 
For some subjects, insufficient evidence was obtained to 
determine if criteria were met for a formal DSM-III-R 
cocaine-related diagnosis; nevertheless, in these cases, 
subjects were clearly established to be chronic cocaine 
users. The presence or absence of cocaine was confirmed 
in urine, liver, or serum samples from all subjects by thin 
layer chromatography. 
TISSUE PREPARATION. Blocks that were obtained at 
the time of autopsy remained at - 80°C until the time of 
study. Each block was slowly warmed to -20°C and 
mounted for cryostat sectioning. Sections were cut 20 ttm 
thick, and were thaw-mounted onto poly-L-lysine subbed 
50 × 75 mm microscope slides. Sections were dried and 
stored at -80°C until further processing. 
IN SlTU HYBRIDIZATION. Sections were removed from 
-80°C storage and placed in 4% formaldehyde at 4°C. 
Slides were fixed for 60 ram, and then processed for in 
situ hybridization as previously described (Meador-Wood- 
ruff et al 1989; Mansour et al 1990; Meador-Woodruff et 
al 1991). Slides were hybridized with [-~sS]-UTP labeled 
riboprobes in 75% formamide hybridization buffer at 55°C 
overnight. Following hybridization, slides were treated with 
RNase A, and washed under progressively more stringent 
conditions, culminating with a 60 rain wash in 0.5 × SSC 
(300 mmol/L NaCl, 30 mmoi/L sodium citrate, pH 7.2) 
at 550C. The slides were then dehydrated in graded al- 
cohols, air-dried, and apposed to Kodak XAR-5 film for 
1-3 weeks. 
A riboprobe to the human DI receptor probe was syn- 
thesized using SP6 RNA polymerase, from a 396 base pair 
(bp) fragment that was subcloned into pGEM-3Z. This 
insert is a Bgl ll-Hind III fragment of a genomic clone for 
the human Di receptor (bases 208-603), which encodes 
the region of the DI receptor between transmembrane do- 
mains II and V and containing the second intracytosolic 
loop. The D2 receptor probe was synthesized using T7 
RNA polymerase from a 446 bp fragment subcloned into 
pGEM-4. This insert contains the region encoding the third 
intracytosolic loop and transmembrane domains VI and 
VII of this receptor, and corresponds to bases 1044-1489 
of a human D2 receptor eDNA. This D2 probe equally 
recognizes both the short and long isoforms of D2 receptor 
messenger ribonucleic acid (mRNA). 
A series of technical control studies was performed to 
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ensure ~e specificity of each riboprobe used in this study, 
as we ~ave previously described (Meador-Woodruff et al 
1989; Mansour et al 1990; Meador-Woodruff et al 1991). 
Both "sense-strand" and RNase-pretreated "antisense"-la- 
beled sections were run in parallel with "antisense"-labeled 
sections. Under the stringent conditions used in this study, 
specific hybridization was observed only in the "anti- 
sense"-labeled condition. 
RECEPTOR AUTORADIOGRAPHY. Preliminary studies 
were performed on slide-mounted human brain sections to 
determine the affinities of [3H]raclopride (69.5 Ci/mmol, 
New England Nuclear) and [~H]SCH23390 (85.6 Ci/mmol, 
New England Nuclear), selective D2 and Dt receptor li- 
gands, respectively. Repeated saturation studies using con- 
centrations of 0.75-10 nmol/L of tritiated ligand suggested 
that [-~Hlraclopride had a mean Kd of 1.62 nmol/L and 
[-~HISCH23390 (in the presence of ! umol/L ketanserin) 
had an affinity of 3.17 nmol/L in human brain tissue. These 
values were valuable in choosing the ligand concentrations 
in normal and cocaine-exposed brains. Three ligand con- 
centrations were used; one at the Kd value, a second at 
1/10the Kd and a third high concentration three times the 
Ka. For [3Hlraclopride, these corresponded to 0.17, 1.55 
and 4.09 nmol/L. For [SH]SCH23390, the concentrations 
were 0.28, 2.97, 9.10 nmol/L. All incubations with 
13HISCH23390 also contained 1 Ixmol/L ketanserin to block 
any binding to 5HT2 receptors. Nonspecific D2 binding 
was defined by 1 I~mol/L ( + )butaclamol while nonspecific 
D~ binding was evaluated with I p,M SCH23390. Although 
three concentrations are not normally sufficient to deter- 
mine K,t and B,,~ values, the limited availability of tissue 
made a more modified procedure necessary. 
Prior to incubation with the tritiated ligands all slides 
were preincubated 15 rain (220C) in a 50 mmol/L "Iris 
buffer (pH 7.4), containing 120 mmol/L NaCi, 5 mmol/L 
KCI, and 1 mmol/L MgCI~. Slides were then dried and 2 
ml of [~HI ligand and buffer (50 mmol/L Tris (pH 7.4), 
120 mmol/L NaCI, 5 mmol/L KCI, ! mmol/L MgCI2, 
0.1% ascorbic acid) at the three concentrations indicated 
earlier was applied to the brain sections. Adjacent sections 
were used to evaluate nonspecific binding at each ligand 
concentration. Incubations were terminated at 90 rain (22°C) 
by four 2-rain ([SHlraclopride) or 4 rain ([SHISCH23390) 
Tris washes (50 mmol/L pH 7.0, 4°C) containing 120 
mmol/L NaCI, 5 mmol/L KCI, 1 mmol/L MgCI2 and 0. !% 
ascorbic acid. Slides were then dipped into distilled water 
(4°C), dried with a hair dryer set to cool, and apposed to 
tritium sensitive Hyperfilm (Amersham) with calibrated 
radioactive standards. 
DATA ANALYSIS. Films from in situ hybridization and 
receptor autoradiography experiments were digitized and 
optical densities in anatomical regions of interest were 
evaluated using quantitative densitometry. Regions of in- 
terest for this study included the nucleus accumbens, can- 
date, and putamen for all riboprobes and radioligands; the 
pars eompacta of the substantia nigra for D2 receptor mRNA 
and binding; and the pars reticulata of the substantia nigra 
for D~ receptor binding. Although the ventr ~1 tegmental 
area was identifiable in the midbrain blocks with a ribo- 
probe to tyrosine hydroxylase mRNA, the probes used in 
this study did not generate a signal that was sufficient to 
convincingly quantify. 
For in situ hybridization films, mean optical density 
values were obtained for each region studied for each probe 
from 8-10 slides per subject. These values were averaged 
to provide a single value for each region and each probe 
for each subject. For quantification of receptor binding, 
the optical density for each region of interest was converted 
to fmoles of ligand bound using calibrated tritium stan- 
dards. Nonspecific binding was subtracted at each ligand 
concentration in each anatomical structure, and the values 
were fitted to Scatehard plots using the LIGAND program 
(Munson and Rodbard 1980). The Kd and Bm,, obtained 
from these data points agreed well with previous results 
using a larger series of concentrations, in all cases, mean 
values were compared by paired two-tailed t-tests, with 
p < 0.05 selected to define significant differences. 
Results 
CLINCIAL ASSESSMENT. As shown in Table 1, co- 
caine-abusing and control subjects were well matched for 
age, gender, race, and postmortem interval. There were 
no significant differences between the two groups for any 
of these items. All of the cocaine-abusing subjects were 
determined to be chronic cocaine users, and all had positive 
toxicology for cocaine at the time of death. None of the 
control subjects had evidence for a substance abuse or 
significant axis I psychiatric diagnosis, and all were free 
of cocaine by toxicological analysis at the time of death. 
DOPAMINE RECEPTOR EXPRESSION. As shown in Fig- 
ure l, there were no significant differences between the 
cocaine-abusing and control groups for dopamine Dt or 
D2 receptor mRNA or binding in any of the three forebrain 
structures studied. Similarly, as demonstrated in Figure 2, 
D2 receptor binding and mRNA as well as DI receptor 
binding were not significantly different between these groups 
in the substantia nigra. The ventral tegmentai area was 
poorly visualizable in these subjects. A comparison was 
made of the medial versus lateral portions of the cells that 
were identifiable in the midbrain, however; there were 
neither medial-lateral differences within either subject group, 
nor were there differences between the groups when corn- 
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Table 1. Clinical and Demographic Characteristics of Subjects 
Cocaine subjects 
Age Race/gender PMI Mode of death Age 
Control subjects 
Race/gender PMI Mode of death 
28 B/F 20 stabbing 
24 W/M 9 stabbing 
32 W/M 18 cardiac 
29 W/M 8 gsw 
37 B/F 9 overdose (cocaine) 
21 B/F 7 gsw 
36 B/M 5 overdose (cocaine) 
39 B/M 7 overdose (cocaine) 













16 ? cardiac 




I I gsw 
PMI: postmortem interval (hours); gsw: gunshot wound; mva: motor vehicle accident. 
paring just the medial or lateral aspects of the substantia 
nigra (data not shown). 
Discussion 
Dopamine Di and D2 receptor expression were not sig- 
nificantly different between cocaine-abusing subjects and 
controls in any of the three forebrain dopaminoiceptive 
regions studied, or in midbrain dopamine-containing cells. 
Previous reports on the effects of cocaine on brain D2 
receptor expression in rats have found different effects in 
the nucleus accumbens versus the striatum. Immediately 
following chronic cocaine treatment in the rat, D2 receptor 
binding has been reported consistently to be elevated in 
the nucleus accumbens (Trulson and Ulissey 1987; Goe- 
ders and Kuhar 1987; Kleven et al 1990; Peris et al 1990). 
Conversely, results in the striatum have been variable, 
being reported as both elevated (Trulson and Ulissey 1987) 
and decreased (Goeders and Kuhar 1987; Kleven et al 
1990). In most studies finding an increase in the accum- 
buns, D2 receptor binding had returned to normal levels a 
week after discontinuation of cocaine (Kleven et al 1990; 
Peris et al 1990). 
Several reports of Di receptor binding following chronic 
cocaine treatment in the rat have also been published. In 
one, both striatal and accumbens DI receptor binding were 
found to be decreased immediately following treatment, 
with the accumbens but not the striatal levels normalizing 
within a week or two (Kleven et al 1990). Another study, 
however, found no changes in either striatal or accumbens 
D~ receptor binding following a week of cocaine treatment 
(Mayfield et al 1992). 
Because species differences may complicate compari- 
son with the current human findings, primate studies are 
of special note. In particular, the size, location, and pos- 
sible functional significance of the nucleus accumbens dif- 
fer in primates versus rodents. One study has examined 
dopamine and other neurotransmitter systems in the rhesus 
monkey following chronic cocaine exposure (Farfel et al 
1992), in contrast to the rat, D2 receptor binding in the 
accumbens, caudate, and substantia nigra was unchanged. 
A significant decrease in D~ binding in the caudate was 
found, however, with no effect in the accumbens. Simi- 
larly, although not statistically significant, there is a trend 
toward decreased levels of Ds receptor mRNA in forebrain 
structures in the present data. Ds receptor binding, how- 
ever, showed equivalent levels in cocaine-using and con- 
trol subjects, suggesting that translational compensation 
may have occurred in the face of an alteration in gene 
transcription. 
The effect of cocaine on D2 receptor binding in the 
human has also been studied in vivo using positron emis- 
sion tomography (PET) (Volkow et al 1990). Cocaine- 
dependent subjects who were withdrawn from cocaine in 
the week prior to study exhibited a decrease in apparent 
D2 receptor binding (as determined by [ISF] N-methylspi- 
roperidoi upt~¢) in the striatum, in contrast, cocaine- 
dependent subjects who had been abstinent for 3 weeks 
were not distinct compared to controls. In our data, there 
is no suggestion of a D2 receptor alteration in any forebrain 
structure. It is somewhat difficult to reconcile these find- 
ings, but may well be related to any number of technicat 
factors, including the use of different radioligands, kinetic 
assumptions made in the PET study, differing limits of 
resolution of the two techniques, and differences in what 
is actually measured in each study (i.e., striatal uptake of 
the tracer in the PET study versus binding of radioligand 
to brain tissue in the present work). As Volkow and as- 
sociates indicate in their report, the use of N-methylspi- 
roperidol in PET to estimate De receptor availability is an 
area of controversy. 
A critical limitation in comparing results from animal 
experiments to the present data is the potential difference 
in frequency of administration of cocaine. In these past 
rodent studies, cocaine was administered at regularly 
scheduled intervals related to drug half-life, presumably 
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Figure 1. Dopamine receptor binding and mRNA in forebrain structures. Dopamine D~ and D2 receptor binding were determined 
with [~H]SCH23390 and [~H]raclopride, respectively, and Dt and D, receptor mRNAs with [3sS]-labeled riboprobes. Results are 
mt ans ± SEM for n = 6 subjects per group. None of the differences between control and cocaine-abusing subjects are significant. 
to maintain sustained brain levels of this drug throughout 
the experiment. In the cocaine-abusing human, however, 
it is unreasonable to expect that the drug will be ingested 
on a regular basis for extended periods due to a number 
of factors, including access and availability of the drug. 
A more likely pattern of cocaine use in the cocaine-de- 
pendent human subject is binging, which could be de- 
scribed as intense but intermittent exposure. None of the 
animal studies reviewed above included self-administra- 
tion, which may best model the human intake pattern. It 
appears that these two receptors are extremely plastic dur- 
ing and after cocaine treatment, as demonstrated by the 
rapid normalization of their expression following cocaine 
withdrawal in these rat studies. The negative findings pre- 
sented in the current work represent dopamine receptor 
status at one uncontrolled time point along a dynamic 
continuum, and the absence of apparent regulation may 
not be altogether unexpected. 
In contrast, cocaine exposure appears to increase bind- 
ing to the presynaptically located dopamine transporter. 
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Figure 2. Dopamine receptor binding and mRNA in the sub- 
stantia nigra. Dopamine Dt and D2 receptor binding were de- 
termined with [aHISCH23390 and [3H]raclopride, and Dz recep- 
tor mRNA with a [3sS]-labeled riboprobe. Results arc pl'esented 
as means -+ SEM with n -- 9 subjects per group. None of the 
differences between control and cocaine-abusing subjects are 
significant. 
withdrawal in these rat studies. The negative findings pre- 
sented in the current work represent dopamine receptor 
status at one uncontrolled time point along a dynamic 
continuum, and the absence of apparent regulation may 
not be altogether unexpected. 
In contrast, cocaine exposure appears to increase bind- 
ing to the presynapticaily located dopamine transporter. 
Striatal tissue from many of ti~ese same subjects included 
in the present study was found to demonstrate a significant 
increase in [3H]WIN35428 (a cocaine congener) binding 
(Little et al 1992). In addition to suggesting that the do- 
pamine transporter is regulated by cocaine in the human ,  
these particular data indicate that the lack of regulation of 
the Dt and Dz receptors in our present work was not caused 
by the lack of chronic cocaine exposure in the subjects. 
There are several limitations to this study that need to 
be acknowledged. By its very design, a postmortem study 
is retrospective, especially in terms of diagnosis and as- 
sessment. Although the chronicity of use of cocaine is 
unquestioned in this subject group, it is unfortunately re- 
constructed from informants. The relatively small number 
of subjects available may also be a factor in explaining 
the lack of statistical findings, but with most group means 
as close as they were, this is unlikely. Postmortem studies 
inherently study a subject at a single point in time, lacking 
the ability to follow a subject, or the regulation of a system, 
in a longitudinal fashion. Despite these limitations, how- 
ever, at the present time, postmortem analysis appears to 
be the only method that is available to image specific gene 
products (i.e., receptor mRNA) in the human brain. 
By examining the mRNAs encoding these dopamine 
receptors, the present study provides an additional level 
of neurochemical information that has not been previously 
available. The simultaneous examination of both binding 
sites and mRNA provides distinct but complementary in- 
formation. By examining both mRNA as well as receptor 
binding, the products of transcription and translation can 
be both indirectly accessed. In addition, the combined use 
of these data provides insight into discrete neuroanatomical 
circuits. D2 receptor binding in the midbrain is likely all 
local, and reflects receptors functioning as autoreceptors 
in the midbrain. D2 receptor mRNA in the midbrain en- 
codes receptors that remain in the midbrain, presumably 
serving as autoreceptors, as well as encoding autoreceptors 
that exist in terminals in the forehrain. D~ receptor binding 
in the midbrain is encoded in the forebrain, which is ex- 
pressed as receptors on terminals in the pars reticulata of 
the substantia nigra. As all of this DI receptor binding is 
encoded by mRNA in cells located more rostraily, no DI 
receptor mlLNA is seen in the mesencephalon; rather, the 
mRNA encoding midbrain D1 receptors is located in the 
forebrain. DI and D2 receptor mRNA in the forebrain 
structures is all associated with intrinsic cells in the regions 
of interest. D2 receptor binding likely is on cell processes 
of both intrinsic cells, as well as on terminals from neurons 
projecting from other regions, such as the cortex', addi- 
tionally, some D2 binding reflects autoreceptors that are 
encoded in the substantia nigra, and is thus associated with 
some of the D2 receptor mRNA visualized in the nigra. 
DI receptor binding in the forebrain is in large part on 
cellular processes from intrinsic cells in the forebrain struc- 
tures. As can be seen, this circuitry is complex, and these 
data provide information concerning the regulation (or lack 
the,~eof) of multiple functional and anatomical levels of 
neural organization. 
Other subtypes of dopamine receptors exist, especially 
in the limbic system. Although the Ds receptor is not 
located in the iimbic or motor dopamine systems (Tiheri 
et al 1991; Meador-Woodruff et ai 1992), D3 and D4 re- 
ceptors are present in the limbic system (Bouthenet et al 
1991; Van Tol et al 1991; Mengod et al 1992; l.Avesque 
et al 1992), although at low levels of expression, It may 
be interesting to determine if one or the other of these 
putatively more "limbic" receptors is influenced by chronic 
cocaine in the human. This may be difficult at this time, 
however, due to the low abundance of mRNAs encoding 
these receptors, as well as due to the lack of a D4-specific 
ligand for receptor autoradiography. 
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